Glioblastoma Metabolism: Insights and Therapeutic Strategies

Chloé Bernhard1, Damien Reita1,2, Sophie Martin1

  • 1UMR CNRS 7021, Laboratory Bioimaging and Pathologies, Tumoral Signaling and Therapeutic Targets, Faculty of Pharmacy, University of Strasbourg, 67405 lllkirch, France.

Insights

Targeting tumor metabolism, especially in glioblastoma, is a promising cancer therapy. This review focuses on metabolic changes in glioblastoma and glioma stem cells to improve treatment strategies.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Neuro-oncology

Background:

  • Glioblastoma (GBM) is a lethal brain tumor resistant to conventional therapies.
  • Glioma stem cells (GSCs) are key drivers of GBM therapy resistance and recurrence.
  • Targeting tumor metabolism presents a novel therapeutic avenue for GBM.

Purpose of the Study:

  • To review metabolic alterations in glioblastoma.
  • To investigate the role of specific metabolic pathways in glioblastoma tumorigenesis.
  • To explore therapeutic strategies targeting glioblastoma and glioma stem cell metabolism.

Main Methods:

  • Literature review of recent advancements in cancer metabolism research.
  • Analysis of metabolic heterogeneity in glioblastoma.
  • Focus on the metabolic characteristics of glioma stem cells.

Main Results:

  • Glioblastoma exhibits significant metabolic heterogeneity.
  • Glioma stem cells possess distinct metabolic profiles supporting their survival and function.
  • Specific metabolic pathways are crucial for glioblastoma development and progression.

Conclusions:

  • Tumor metabolism is a viable therapeutic target for glioblastoma.
  • Understanding GSC metabolism is critical for overcoming therapy resistance.
  • Targeted metabolic interventions may improve glioblastoma treatment outcomes.